These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5723994)

  • 1. Analysis of the cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (Catapres).
    Constantine JW; McShane WK
    Eur J Pharmacol; 1968 Sep; 4(2):109-23. PubMed ID: 5723994
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of the pressor and depressor actions of St 155 (2-(2,6--dichlorophenylamino)-2-imidazoline hydrochloride, Catapres).
    Rand MJ; Wilson J
    Eur J Pharmacol; 1968 Apr; 3(1):27-33. PubMed ID: 5658985
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). I. Peripheral sympathetic system.
    Boissier JR; Giudicelli JF; Fichelle J; Schmitt H; Schmitt H
    Eur J Pharmacol; 1968 Mar; 2(5):333-9. PubMed ID: 5663498
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative pharmacodynamics of sympathomimetic imidazolines; studies on intestinal smooth muscle of the rabbit and the cardiovascular system of the cat.
    Mujić M; van Rossum JM
    Arch Int Pharmacodyn Ther; 1965 Jun; 155(2):432-49. PubMed ID: 5841192
    [No Abstract]   [Full Text] [Related]  

  • 5. An effect of ST 155 (clonidine), 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, Catapres on relationship between blood pressure and heart rate in dogs.
    Nayler WG; Stone J
    Eur J Pharmacol; 1970 May; 10(2):161-7. PubMed ID: 5446372
    [No Abstract]   [Full Text] [Related]  

  • 6. An involvement of St 155 [2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, catapres] in cholinergic mechanisms.
    Robson RD; Kaplan HR
    Eur J Pharmacol; 1969 Mar; 5(4):328-37. PubMed ID: 4389147
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodynamic effects of ST 155, 2-(2,6 dichlorophenylamino)-2 imidazoline hydrochloride, in hypertensive dogs].
    Laubie M; Schmitt H
    Arch Int Pharmacodyn Ther; 1969 May; 179(1):23-5. PubMed ID: 5348396
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of 2-(2,6-dichlorphenylamine)-2-imidazoline hydrochloride (Catapres) upon the systemic and coronary haemodynamics and metabolism of intact dogs.
    Maxwell GM
    Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):7-14. PubMed ID: 5350786
    [No Abstract]   [Full Text] [Related]  

  • 9. Further observations on the cardiovascular effects of ST 155 (Catapres).
    Nayler WG; Price JM; Stone J; Lowe TE
    J Pharmacol Exp Ther; 1969 Apr; 166(2):364-73. PubMed ID: 5776992
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the alpha-adrenergic effects of large doses of isoprenaline].
    Giudicelli R; Lefèvre F
    C R Seances Soc Biol Fil; 1967 Jul; 161(2):284-8. PubMed ID: 4229124
    [No Abstract]   [Full Text] [Related]  

  • 11. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
    Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
    J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
    [No Abstract]   [Full Text] [Related]  

  • 12. Localization of the hypotenisve effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan).
    Schmitt H; Schmitt H
    Eur J Pharmacol; 1969 Apr; 6(1):8-12. PubMed ID: 4306572
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the hypotensive drug ST 155 (Catapres) on the heart and peripheral circulation.
    Nayler WG; Price JM; Swann JB; McInnes I; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Nov; 164(1):45-59. PubMed ID: 5722106
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular studies on aminocaproic acid.
    Cummings JR; Welter AN
    Toxicol Appl Pharmacol; 1966 Jul; 9(1):57-69. PubMed ID: 5967567
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological effects of a new antihypertensive agent with imidazoline structure].
    Hoefke W; Kobinger W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):28-9. PubMed ID: 4231841
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of tyramine responses by nor-sympathomimetic amines in the reserpine-pretreated cat.
    Murnaghan MF
    Arch Int Pharmacodyn Ther; 1965 Jun; 155(2):332-55. PubMed ID: 5841189
    [No Abstract]   [Full Text] [Related]  

  • 17. On the pharmacology of guanoxan.
    Vidal-Beretervide K; Pritsch LE; Trinidad H
    Arzneimittelforschung; 1969 Jun; 19(6):947-51. PubMed ID: 4389903
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl.
    Kobinger W; Walland A
    Eur J Pharmacol; 1967 Dec; 2(3):155-62. PubMed ID: 5626889
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155) in the cat.
    Magus RD; Long JP
    J Pharm Sci; 1968 Apr; 57(4):594-8. PubMed ID: 5652149
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison between the effects of ST 600 and catapres.
    Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):347-50. PubMed ID: 1156039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.